Global Trends in the Burden of Ischemic Stroke Attributable to Diabetes Versus Atrial Fibrillation

Introduction

Ischemic stroke (IS) is a leading cause of disability and mortality worldwide, resulting from an obstruction in blood vessels supplying the brain. Among its various causes, atrial fibrillation (AF)—an irregular and often rapid heart rhythm—and diabetes mellitus stand out as significant but mechanistically distinct contributors. AF-related ischemic stroke primarily results from cardioembolic events due to turbulent heart rhythms, whereas diabetes-related ischemic stroke often reflects widespread vascular damage due to chronic metabolic dysfunction affecting multiple vascular beds, a condition termed panvascular disease.

Understanding global burden trends of IS attributable to these two factors provides valuable insight into public health priorities and resource allocation. This article presents an analysis, based on the Global Burden of Disease (GBD) 2021 dataset, examining incidence patterns, regional variations, and future projections for IS related to AF versus diabetes.

Methods

The analysis quantified disease burden by measuring the population-attributable fraction (PAF)—the proportion of ischemic stroke cases preventable if atrial fibrillation or diabetes was eliminated as a risk factor. This approach allows a clearer picture of risk factor impact over time.

Data were stratified by year, geographic region, and age group. Statistical methods included joinpoint regression to identify shifts in trends, time-series projection modeling extending through 2050, and detailed age- and sex-specific analyses to characterize population subgroups. The study also identified common and unique risk factors contributing to these stroke subtypes.

Results

Globally, the age-standardized incidence rate of AF-related ischemic stroke was higher than that of diabetes-related IS in 1990. However, AF-related IS incidence showed a gradual but significant decline over the subsequent decades, with an average annual percentage change of -0.81% (95% CI -0.92 to -0.69). This decline reflects improved detection and management of AF, including widespread adoption of anticoagulation therapy and better cardiovascular care.

In contrast, diabetes-related IS started from a lower incidence in 1990 but exhibited a sustained, substantial increase, with an average annual percentage change of +1.10% (95% CI 1.02 to 1.18). This rise aligns with the global increase in diabetes prevalence driven by aging populations, obesity, sedentary lifestyles, and urbanization.

Regionally, middle to high socio-demographic index (SDI) countries bore the greatest combined burden of AF- and diabetes-related ischemic strokes. Notably, in North America and Eastern Europe, AF-related IS incidence rates stabilized or continued their decline (annual changes of -1.45% and -0.95%, respectively). However, diabetes-related IS incidence in these regions kept rising steadily (+1.18% and +0.72%, respectively), signaling a persisting challenge.

Obesity, measured by high body mass index (BMI), emerged as a critical modifiable risk factor shared between AF, diabetes, and ischemic stroke. Its prevalence fuels the diabetes epidemic and is also linked to increased AF risk, thus compounding stroke risk.

Projections indicate that over the next three decades, diabetes-related ischemic stroke incidence is expected to increase markedly worldwide, while AF-related stroke incidence will show minimal growth or stabilize. This forecast emphasizes the shifting burden of stroke towards metabolic causes.

Discussion

The diverging trends in ischemic stroke attributable to AF and diabetes highlight important public health and clinical implications. The global decline in AF-related stroke incidence likely reflects advances in identification, stroke prophylaxis via anticoagulation, and managing coexisting cardiovascular risk factors.

Conversely, the rising diabetes-related IS burden signals a need for intensified efforts focusing on diabetes prevention, early diagnosis, and comprehensive vascular risk management. Since diabetes-driven strokes reflect systemic vascular damage, controlling hyperglycemia and associated risk factors like hypertension and dyslipidemia is crucial.

Further, high BMI’s role in elevating both AF and diabetes risks underlines the importance of population-level interventions targeting obesity through lifestyle modification and policy measures.

Implications for Practice and Policy

Tailored strategies are needed to address these diverging trends:

1. For AF-related stroke, continued emphasis on screening for atrial fibrillation in at-risk populations, widespread use of anticoagulants, and management of cardiac comorbidities remain essential.

2. For diabetes-related stroke, expanding prevention programs addressing obesity, promoting physical activity, healthy diets, and early identification of glucose abnormalities are key. Additionally, integrated care pathways managing multi-morbidity in diabetic patients can mitigate vascular complications.

3. Health systems particularly in middle to high SDI countries should prioritize resource allocation to manage the dual challenge of AF and rising diabetes-associated stroke.

Conclusion

Ischemic stroke continues to be a global health challenge with substantial morbidity and mortality. This comprehensive analysis underscores the rising dominance of diabetes as a driver of ischemic stroke worldwide, in contrast to the declining trends in AF-related stroke. Addressing this evolving burden requires age- and country-specific interventions that integrate primary prevention, risk factor control, and optimized clinical management, particularly with emphasis on tackling obesity and diabetes.

Further Research

Continued surveillance using updated global datasets will be vital for monitoring these trends and evaluating the effectiveness of interventions. Research into novel therapies targeting diabetes-induced vascular damage and personalized approaches to stroke prevention could further improve outcomes. Understanding the interplay between AF, diabetes, and other cardiovascular risks at a mechanistic level may unlock new preventive or therapeutic strategies.

References

Wang L, Lin F, Chen Y, et al. Global Trends in the Burden of Ischemic Stroke Attributable to Diabetes Versus Atrial Fibrillation. Stroke. 2026;57(9):2754-2767. doi:10.1161/STROKEAHA.126.42464804